The private capital markets are undergoing a seismic shift, driven by macroeconomic challenges, regulatory pressures, and increasing demands for transparency. Among the most transformative forces shaping the industry is artificial intelligence (AI).
According to private capital markets technology firm, Allvue, their 2025 GP Outlook Report states that while 82% of private equity and venture capital firms have adopted AI in some form, only 4% report extensive use. In contrast, industries like marketing and pharmaceuticals have embraced AI more aggressively, leveraging it for personalization, predictive analytics, and drug discovery.
This disparity raises a crucial question: What lessons can private capital markets learn from these industries to accelerate AI adoption?
THE STATE OF AI IN PRIVATE CAPITAL MARKETS
Despite the buzz around AI, private capital firms remain cautious. While 54% of firms recognize AI as a potential competitive differentiator, barriers such as unclear ROI, regulatory concerns, and a lack of skilled personnel have slowed widespread implementation. AI in this space primarily supports operational efficiency, data management, client reporting, and risk management, yet firms struggle with integrating AI-driven insights into their decision-making processes.
A key challenge lies in data readiness. With 88% of firms identifying data and analytics as crucial, issues such as data accuracy and aggregation present roadblocks to AI’s full potential. Additionally, only 6% of firms express strong satisfaction with their data management solutions, highlighting an urgent need for better AI-driven data infrastructure.
LESSONS FROM MARKETING: HYPER-PERSONALIZATION & AUTOMATION
Marketing has been a frontrunner in AI adoption, using machine learning to automate customer interactions, personalize content, and optimize ad targeting. Companies like Salesforce leverage AI-powered CRM tools, enabling businesses to predict customer behavior, enhance engagement, and drive conversions. By contrast, private capital firms are still in the early stages of AI adoption for investor relations and deal sourcing.
The lesson? Private capital firms can take inspiration from marketing’s AI-driven automation strategies to enhance investor communication, streamline fundraising, and improve portfolio management through predictive insights.
LESSONS FROM PHARMACEUTICALS: USING AI IN A HIGHLY REGULATED INDUSTRY FOR RISK ANALYSIS AND PREDICTIVE MODELING
The pharmaceutical industry has embraced AI for drug discovery, clinical trials, and patient diagnosis. IBM’s Watson Health, for example, uses AI to analyze vast medical datasets, accelerating drug development timelines and improving clinical outcomes. In the private markets, AI’s potential for risk assessment, predictive modeling, and fraud detection remains largely untapped.
Private equity firms can borrow from pharma’s playbook by leveraging AI for deeper due diligence, risk modeling, and market predictions. AI can identify trends in deal flow, assess potential risks, and optimize investment strategies, enabling firms to make data-driven decisions faster and with greater confidence.
THE PATH FORWARD: AI AS A COMPETITIVE ADVANTAGE
To close the AI adoption gap, private capital firms must take a proactive approach:
- Invest in AI-Ready Data Infrastructure – Clean, structured, and integrated data is essential for AI’s success.
- Develop AI Talent & Expertise – Addressing the skills gap through hiring and training will accelerate adoption.
- Adopt AI for Decision-Making – Beyond back-office efficiency, AI must play a role in investment strategies and risk assessment.
- Learn from Other Industries – By studying AI adoption in marketing and pharma, private capital firms can implement best practices and avoid common pitfalls.
While the private capital markets may be slower to adopt AI than other industries, the potential for transformation is vast. By embracing AI with a strategic mindset, firms can not only enhance operational efficiency but also gain a lasting competitive edge in an increasingly complex market landscape. The future belongs to those who leverage AI effectively. Will private capital markets rise to the challenge?